Gilead Sciences Inc. (GILD)
NASDAQ
Closed
Oct 19, 2026
Day's Range
152.9252 wk Range
114.02Overview - GILD - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
211.07B
P/E (Trailing)
‪17.86‬
P/E (Forward)
‪15.37‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪6.23‬
Price / Book
‪16.05‬
EV / EBITDA
‪14.45‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Short % of Shares Outstanding
‪1.76%‬
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.07%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪147.23‬
200-Day Avg
‪138.18‬
Dividends
Payout Ratio
‪43.46%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 157.41‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GILD - Gilead Sciences Inc.
Peers - GILD - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- GILDNASDAQGilead Sciences, Inc.186.52BMarket Cap+21.42%52-week change17.87P/E (Trailing)‪-10.63%‬Profit Margin
- AZNNASDAQAstraZeneca PLC American Depositary Shares256.53BMarket Cap-1.41%52-week change23.77P/E (Trailing)‪17.02%‬Profit Margin
- AMGNNASDAQAmgen Inc. Common Stock223.19BMarket Cap+28.82%52-week change25.64P/E (Trailing)‪22.95%‬Profit Margin
- SNYNASDAQSanofi ADR95.22BMarket Cap-22.80%52-week change21.20P/E (Trailing)‪8.09%‬Profit Margin
- ROPNASDAQRoper Technologies Inc.37.85BMarket Cap-32.19%52-week change15.76P/E (Trailing)‪30.24%‬Profit Margin
- BIIBNASDAQBiogen Inc.33.89BMarket Cap+36.93%52-week change40.09P/E (Trailing)‪8.32%‬Profit Margin
- GRFSNASDAQGrifols S.A. ADR5.19BMarket Cap-25.26%52-week change9.92P/E (Trailing)‪6.09%‬Profit Margin
Profile Summary - GILD - Gilead Sciences Inc.
About
Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, oncology, inflammation, respiratory conditions, and cardiovascular…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
